Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by aliasunknownon Jul 17, 2018 11:29am

193 Views

Post# 28326962

RE:ANTIBE: Market Cap of $3 Billion?

SergeantSanderz wrote: As ANTIBE prepares to conduct the FINAL Phase 2 clinical trial for its lead drug, ATB-346, many eyes are watching (including SHORTERS who want a lower entry point). If successful, along with potential of the other H2S-utilizing drugs in its pipeline we might see ANTIBE with a market cap worth billions down the road.

There is no guarantee, of course, but ANTIBE has many notes of promise and its recent release of the secondary endpoint data indicates strong potential.

As always, do your own due diligence. Personally, I'm happy to wait for further results.

As an aside, if ANTIBE reaches a market cap of $3 Billion, that would give use $11.58 per share.

Hold LONG and ignore the SHORTERS: they want your shares!

JMO, SergeantSanderz

What shorts are you talking about?...............................

General Information
Trading Status:	TRADING	Ex Dividend:	N
Type:	EQUITY	Currency:	CDN
Sub Type:	COMMON	Market Tier:	Tier2
Listed Date:	18/Jun/2013

Security Description/Comments

New Listing-IPO -shares

Short Summary
Short Volume	As Of
21,110	30/Jun/2018
108,483	15/Jun/2018
30,100	31/May/2018

Trading History
	This Week	This Month	This Year	Last Year
High:	0.375	0.410	0.790	0.285
Low:	0.360	0.360	0.150	0.080
Close:	0.365	0.365	0.365	0.145

All Time Records
High:	0.880	07/Mar/2014	Volume:	17,412,791	20/Mar/2018
Low:	0.040	26/Jan/2015	Value:	11,070,017.82	20/Mar/2018
			# Trades:	3,927	20/Mar/2018